We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Mattel
MAT
$4.47B
| $17.3M | 0.04% |
676,745
-7,625
| -1% | -$204K |
|
452
Wynn Resorts
WYNN
$10.3B
| $17.2M | 0.04% |
150,323
+4,750
| +3% | +$474K |
|
453
Affiliated Managers Group
AMG
$9.51B
| $17.2M | 0.04% |
104,785
+4,750
| +5% | +$752K |
|
454
PVH
PVH
$4.07B
| $17.1M | 0.04% |
165,749
+6,161
| +4% | +$570K |
|
455
Goodyear
GT
$2.09B
| $17.1M | 0.04% |
475,411
+15,882
| +3% | +$539K |
|
456
JB Hunt Transport Services
JBHT
$25.9B
| $17.1M | 0.04% |
185,955
+4,119
| +2% | +$399K |
|
457
LKQ Corp
LKQ
$6.72B
| $17M | 0.04% |
582,080
+14,064
| +2% | +$437K |
|
458
ServiceNow
NOW
$120B
| $17M | 0.04% |
973,885
+60,540
| +7% | +$1.06M |
|
459
Steel Dynamics
STLD
$36.2B
| $17M | 0.04% |
488,739
+16,818
| +4% | +$599K |
|
460
Align Technology
ALGN
$12.9B
| $17M | 0.04% |
147,927
+4,804
| +3% | +$485K |
|
461
Teleflex
TFX
$5.96B
| $16.9M | 0.04% |
87,488
+4,064
| +5% | +$732K |
|
462
Alliant Energy
LNT
$18.6B
| $16.9M | 0.04% |
426,874
-9,171
| -2% | -$352K |
|
|
SCG
463
DELISTED
Scana
SCG
| $16.9M | 0.04% |
258,318
-10,187
| -4% | -$703K |
|
|
KSU
464
DELISTED
Kansas City Southern
KSU
| $16.8M | 0.04% |
195,673
+7,259
| +4% | +$622K |
|
465
VeriSign
VRSN
$26.3B
| $16.8M | 0.04% |
192,298
+4,395
| +2% | +$365K |
|
466
Markel Group
MKL
$25.2B
| $16.7M | 0.04% |
17,158
+878
| +5% | +$830K |
|
|
MXIM
467
DELISTED
Maxim Integrated Products
MXIM
| $16.7M | 0.04% |
370,870
+12,277
| +3% | +$538K |
|
468
NVR
NVR
$17.1B
| $16.6M | 0.04% |
7,888
+320
| +4% | +$606K |
|
469
Corpay
CPAY
$25.7B
| $16.6M | 0.04% |
109,744
+7,100
| +7% | +$1.11M |
|
470
Arch Capital
ACGL
$35.7B
| $16.5M | 0.04% |
522,747
+38,424
| +8% | +$1.17M |
|
|
ETFC
471
DELISTED
E*Trade Financial Corporation
ETFC
| $16.5M | 0.04% |
473,288
+22,789
| +5% | +$817K |
|
472
Celanese
CE
$4.82B
| $16.5M | 0.04% |
183,439
+8,715
| +5% | +$761K |
|
473
Macy's
M
$6.51B
| $16.5M | 0.04% |
555,179
-1,572
| -0.3% | -$48.6K |
|
474
MarketAxess Holdings
MKTX
$4.47B
| $16.4M | 0.04% |
87,710
+2,645
| +3% | +$479K |
|
475
A.O. Smith
AOS
$8.55B
| $16.4M | 0.04% |
320,426
+34,008
| +12% | +$1.69M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.